ELMTINA

ELMTINA TABLET (Wych Elm Laboratories Limited) with a composition of Linagliptin 2.5 mg + Metformin Hcl 500 mg Tablet.

Elmtina 2.5mg/500mg Tablet is a combination of two medicines used to help control high blood sugar levels in people with type 2 diabetes mellitus. It works by improving insulin action and reducing the amount of sugar produced by the liver.

Elmtina 2.5mg/500mg Tablet may be prescribed alone or together with other diabetes medications. It works best when combined with a healthy diet and regular exercise. The dosage depends on your condition, blood sugar levels, and other medications you are taking. Taking it with meals can help minimize the risk of an upset stomach. Take Elmtina 2.5mg/500mg Tablet exactly as prescribed by your doctor.

Follow the recommended schedule to achieve the best results. Do not make changes to your dosage or stop taking it without consulting your doctor. Continue following the diet and exercise plan recommended by your doctor while using this medicine. Your lifestyle plays a big part in controlling diabetes.

The most common side effects of taking this medicine include headache, nausea, dizziness, and skin rash. Some people may experience low blood sugar (hypoglycaemia), especially when taking this medicine with other diabetes treatments like insulin or sulfonylureas. If these side effects persist or worsen, consult your doctor.

Before taking Elmtina 2.5mg/500mg Tablet, inform your doctor if you have a history of kidney, liver, or heart disease or any pancreatic issues. Pregnant or breastfeeding women should also consult their doctor before taking this medicine. Some medicines can interact and affect the effectiveness of Elmtina 2.5mg/500mg Tablet; tell your doctor about all the medicines you are taking to ensure it is safe for you. Avoid drinking alcohol, as it can lower blood sugar levels. Your doctor will monitor your kidney function and blood sugar levels before and during treatment. Elmtina 2.5mg/500mg Tablet should not be used to treat type 1 diabetes.

1. Treatment of Type 2 diabetes mellitus
2.  Elmtina used in the treatment of Type 2 Diabetes Mellitus. 
3. The detailed uses of Elmtina are as follows: 

• Improving Glycaemic Control: Elmtina helps to improve blood sugar control in adults with Type 2 Diabetes.
• Reducing Insulin Resistance: Elmtina reduces insulin resistance and increases insulin release. 
• Lowering Blood Sugar: Elmtina lowers blood sugar levels, reducing the risk of diabetes-related complications.

In Treatment of Type 2 diabetes mellitus

Elmtina 2.5mg/500mg Tablet has two active substances in it i.e. metformin and linagliptin. Metformin belongs to a class of medicines called biguanides. Linagliptin belongs to a group called DPP-4 inhibitors. They work together in different ways to lower your blood glucose levels.

Lowering blood glucose levels is an essential part of managing diabetes. If you can control your blood glucose level, your risk of getting any of the serious complications of diabetes such as kidney damage, eye damage, nerve problems, and loss of limbs is also lowered. Additionally, proper control of diabetes can also reduce the risk of heart disease and stroke. Taking this medicine regularly along with a proper program of diet and exercise will help you live a normal, healthy life. You should keep using this medicine for as long as it is prescribed because it is protecting your future health.

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Common side effects of Elmtina

• Nausea
• Headache
• Dizziness
• Vomiting
• Fatigue
• Skin rash
• Abnormal liver function

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Elmtina 2.5mg/500mg Tablet is to be taken with food.

Elmtina 2.5mg/500mg Tablet is a combination of two medicines: metformin and linagliptin. Metformin is an antidiabetic medication (biguanide). It lowers glucose production in the liver, slows glucose absorption in the intestine, and improves the body's insulin sensitivity. Linagliptin, a DPP-4 inhibitor, increases insulin release from the pancreas and reduces hormones that raise blood sugar levels. This reduces both fasting and post-meal sugar levels. Together, they provide better control of blood sugar.

Alcohol

UNSAFE

It is unsafe to consume alcohol with Elmtina 2.5mg/500mg Tablet.

Pregnancy

CONSULT YOUR DOCTOR

Elmtina 2.5mg/500mg Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.

Breast feeding

UNSAFE

Elmtina 2.5mg/500mg Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.

Driving

CAUTION

Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.

Kidney

CONSULT YOUR DOCTOR

There is limited information available on the use of Elmtina 2.5mg/500mg Tablet in patients with kidney disease. Please consult your doctor.

Liver

CONSULT YOUR DOCTOR

There is limited information available on the use of Elmtina 2.5mg/500mg Tablet in patients with liver disease. Please consult your doctor.

If you miss a dose of Elmtina 2.5mg/500mg Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.

• Elmtina 2.5mg/500mg Tablet should be taken with food to lower the chances of having an upset stomach.
• Take it along with regular exercise and a healthy diet to help lower blood sugar levels.
• Hypoglycaemia (low blood sugar level) may occur when taken along with other antidiabetic medicines, alcohol, or by delaying/skipping a meal. Carry a sugar source with you for immediate relief.
• Monitor your blood sugar level regularly while on treatment with this medicine.
• Inform your doctor about your diabetes treatment if you are due to have any surgery under a general anaesthetic.
• Tell your doctor immediately if you experience any deep or rapid breathing, persistent nausea, vomiting, or stomach pain, as Elmtina 2.5mg/500mg Tablet may cause a rare but serious condition called lactic acidosis, which is an excess of lactic acid in the blood.

Q: Does the use of Elmtina 2.5mg/500mg Tablet cause lactic acidosis?

A:Yes, the use of Elmtina 2.5mg/500mg Tablet can lead to lactic acidosis, which is also known as MALA (metformin-associated lactic acidosis). It is caused by increased levels of lactic acid in the blood. It is a very rare side effect associated with the use of metformin, and therefore, it is avoided in patients with underlying kidney disease, elderly patients, or those who consume large amounts of alcohol. Symptoms of lactic acidosis may include muscle pain or weakness, dizziness, tiredness, feeling cold in arms and legs, difficulty in breathing, nausea, vomiting, stomach pain, or slow heart rate. If you have these symptoms, stop taking Elmtina 2.5mg/500mg Tablet and immediately consult your doctor.

Q: What are the possible side effects of Elmtina 2.5mg/500mg Tablet?

A:The use of Elmtina 2.5mg/500mg Tablet may cause some common side effects like nausea, headache, dizziness, fatigue, vomiting, and skin rash. Patients may also experience hypoglycaemia (low blood sugar level) when taken along with other antidiabetic medicines. It can also lead to a serious but rare side effect known as lactic acidosis. Additionally, its long-term use can also lead to vitamin B12 deficiency.

Q: Are there any specific conditions in which Elmtina 2.5mg/500mg Tablet should not be taken?

A:The use of Elmtina 2.5mg/500mg Tablet should be avoided in patients with known allergies to any of the components of this medicine. The use of this medicine should be avoided in patients with severe kidney impairment, liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis. Therefore, consult your doctor before using Elmtina 2.5mg/500mg Tablet.

Q: Is it safe to drink alcohol while I am also taking Elmtina 2.5mg/500mg Tablet?

A:No, it is not safe to take Elmtina 2.5mg/500mg Tablet with alcohol. Doing so can increase the chances of lactic acidosis, particularly in cases of fasting, malnutrition, or kidney dysfunction. However, if you are not sure, consult your doctor.

Q: Can the use of Elmtina 2.5mg/500mg Tablet cause hypoglycaemia?

A:The use of Elmtina 2.5mg/500mg Tablet does not usually cause hypoglycaemia (low blood sugar level) on its own. However, it may occur if there is not enough calorie intake while using this medicine. Symptoms of hypoglycaemia include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. The symptoms are more likely to be noticed if you miss or delay your food, drink alcohol, overexercise, or take any other antidiabetic medicine along with it. Hence, regular monitoring of blood sugar levels is important. It is recommended to always carry glucose tablets, honey, or fruit juice with you.

Q: Can the use of Elmtina 2.5mg/500mg Tablet lead to vitamin B12 deficiency?

A:Yes, long-term use of Elmtina 2.5mg/500mg Tablet can cause vitamin B12 deficiency as it interferes with the absorption of vitamin B12 in the stomach. If untreated, it may cause anaemia and nerve problems. These may further cause a tingling sensation and numbness in hands and feet, weakness, urinary problems, change in mental status, and difficulty in maintaining balance (ataxia). Consult your doctor if you experience these symptoms. Your doctor may advise monitoring of B12 levels and prescribe a vitamin B12 supplement if required.

Q: What are the instructions for the storage and disposal of Elmtina 2.5mg/500mg Tablet?

A:Keep this medicine tightly closed in the packet or the container it came in. Store it according to the instructions mentioned on the pack or label. Dispose the unused medicine. Make sure it is not consumed by pets, children, or other people.